StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Credit Suisse Upgrades Merck (MRK) to Outperform
August 8, 2016 6:22 AM
Credit Suisse upgraded Merck (NYSE: MRK) from Neutral to Outperform with a price target of $73.00 following news Friday that ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Upgrades
Next Articles
BMO Capital Upgrades Merck (MRK) to Outperform, $72 PT
August 5, 2016 12:25 PM
Deutsche Bank Comments on Bristol-Myers Squibb (BMY) Opdivo News; Analyst Says Merck (MRK) Not Guaranteed to be Alone in Front-Line Setting
August 5, 2016 11:25 AM
Bristol-Myers (BMY) Opdivo Trial Miss a 'Seismic Event', BMO Capital Says (MRK)
August 5, 2016 10:00 AM
Merck (MRK) Surges After Bristol-Myers Squibb's (BMY) CheckMate -026 Trial Fails
August 5, 2016 8:24 AM